Zachary R.

Zachary R. has a diverse work experience background. Zachary co-founded and served as CEO of Sigma Genetics, Inc., a company focused on developing ex vivo biotechnology for delivering charged molecules into patient cells using magnetic fields. Zachary also worked as an investor for several companies including InnaMed, Earth AI, OncoSenX, Oisin Biotechnologies, and Umba. Zachary co-founded PhenoMx, Inc., where they contributed as a member of the Board of Directors. Additionally, Zachary worked as the Director of Business Development at Altoida, Inc., a company specializing in early detection of Alzheimer's disease through the use of neuromotor biomarkers and augmented reality technology. Prior to these roles, they worked as an Associate Consultant at Pharmagellan, a Senior Associate Researcher at the Icahn School of Medicine at Mount Sinai, and an Assistant Editor at Harvard University.

Zachary R. pursued a Bachelor of Arts degree in Biological Anthropology from Drew University. After completing their undergraduate studies, they furthered their education at Columbia University Graduate School of Arts and Sciences, specializing in Biotechnology and successfully obtained a Master of Arts degree.